31O. Biochemical Approach to Cause of Premature Rupture of Membranes : Collagen Degradation in Amnion Due to Neutrophil and Meconium
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本産科婦人科学会の論文
- 1986-08-01
著者
-
Terao T.
Dept. Obs & Gyn, Hamamatsu University School of Medicine
-
Terao T.
Hamamatsu University School Of Medicine
-
Sumimoto K.
Dept. Obst. and Gynec., Hamamatsu Univ. Sch. Med.,
-
HAYATA T.
Dept. Obst. & Gynec. Hamamatsu Univ. Sch. Med.
-
KANAYAMA N.
Dept. Obst. & Gynec. Hamamatsu Univ. Sch. Med.
-
SUGIMURA M.
Dept. Obst. & Gynec., Hamamatsu Unv. Sch. Med.
-
Sumimoto K.
Hamamatsu University School Of Medicine
-
OYAMADA H.
Dept. Obst. & Gynec., Hamamatsu Univ. Sch. Med.
-
Kawashima Y.
Dept. Obst. And Gynec. Hamamatu Univ. Sch. Med.
-
Hayata T.
Dept. Obst. & Gynec. Hamamatsu Univ. Sch. Med.
-
Kawashima Y.
Dept. Obst. And Gynec. Hamamatsu Univ. Sch. Med.
-
Terao T.
Department Of Obstetrics And Gynecology Hamamatsu University School Of Medicine
-
Kanayama N.
Department Of Obstetrics And Gynecology Hamamatsu University Of Medicine
-
Oyamada H.
Dept. Obst. & Gynec. Hamamatsu Univ. Sch. Med.
-
Sugimura M.
Dept. Obst. And Gyn. Hamamatsu Univ. Sch. Med.
-
Kawashima Y.
Dept. Obst. And Gyn. Hamamatsu Univ. Sch. Med.
関連論文
- IS-39 Soluble form of plasma P-selectin (GMP-140) and Glycocalicin are elevated in preeclampsia and eclampsia : their significance.
- IS-46 Blood coagulation and fibrinolysis in eclamptic patients and its correlation with the clinical signs.
- Blood Coagulation and Fibrinolysis in Eclamptic Patients and their Correlation with the Clinical Signs
- Correlated Plasma Elastase and Sera Cytotoxicity in Eclampsia : Role of Neutrophil Activation in Preeclampsia-eclampsia
- 526 ATLA antibody screening in pregnant women and significance of Western Blot (WB) method as a secondary test.
- 110. A Study on Relationship of Uterine Anomaly to Infertility
- 32. Analysis of Collagen Components in Uterine Adenomyosis
- 520. Comparative Study of EIA and PA Test in Screening Pregnant Women for anti-ATLA Antibodies
- 94.The Finding of Over-shoot Acceleration and Sinusoidal Heart Rate Pattern in Anencephalic Cases
- 40. Clinical Finding of Follicle Atresia and Hyperprolactinemia in Controlled Ovarian Stimulation
- 403. Efficacy of, New MECA Therapy in High Risk Choriocarcinoma
- 183. Prevention of Vertical Transmission of Hepatitis B Virus
- 94. Significance of the Overshoot Acceleration in FHR Monitoring
- 373. Prevention of Vertical Transmission of Hepatitis B Virus
- 167. Catecholamine Surge and Prolactin Levels during Delivery
- 79.FHR Changes of Multiple Pregnancies and their Prognoses : XIII Fetus, Neonate and ME(I)
- 77.Correlation between STV and LTV in Dissociative Cases : XIII Fetus, Neonate and ME(I)
- 423.Prevention of Vertical Transmission of Hepatitis B Virus : XXXXXXXII Infectious Disease(II)
- 410.Immunohistochemical CEA & hCG in 63 Cases of Ovarian Tumors : With Particular Reference to the Significance of Simultaneous Estimations of Both Tumor Markers in Plasma : XXXXXXX Ovarian Tumor(IV)
- 221.Clinical Significance of Heart Rate Monitoring during the Perinatal Stage : XXXVII Fetus and Neonate(VI)
- 321 Chronic Daily Low-dose Administration of Oral Etoposide in Advanced Epitherial Ovarian Cancer.
- 365 Prognostic significance of the DNA content of uterine corpus cancer.
- 71 Characteristics of localization of human papillomavirus DNA and expression of epidermal growth factor receptor in cervical cancer.
- 254. Clinical Usefulness of Combination Assay and Discriminant Analysis Using the Values of CA125, TPA, Ferritin, CEA, AFP and PPA in Patients with Gynecological Malignant Diseases
- 11. The Delivery of the Patient with LDH M Subunit Deficiency
- 72.Placental Plasminogen Activator and Placental Urokinase Inhibitor in the Toxemia of Pregnancy : XII Pregnancy, Labor and Puerperium(III)
- 120.The Role of Inhibition of Urinary Fibrinolysis in Toxemic Pregnant Women : XX Hematology(I)
- 97.Cytotoxicity of T Lymphocytes from a Patient with Choriocarcinoma to Autologous Tumor Cultured Cells : XVI Immunology(I)
- 41. Studies on the Malignant Profile of Destructive Mole
- 100 Studies on the localization and the origin of the blood coagulation factor XIII subunit A (XIIIA) of the secretory phase endometrium and the placenta.
- 80 Studies on the localization of adhesive proteins of the endometrium under various coditions.
- 155 A case of maternal death due to fluminant hepatic failure : acute lymphocytic leukemia in pregnancy.
- 76 Studies on the localization of adhesive factors at the site of implantation in the early pregnancy.
- 537 Changes in plasma PAI 1, PAI 2 and tPA antigen in normal pregnant and preeclamptic pregnant women.
- 535 Study on the hypercoagulability during pregnancy.
- 38 A report of peripartum course in a patient with congenital factor XII deficiency.
- 364 Protein C inhibitor and its complex in normal pregnant and preeclamptic pregnant plasma.
- 95 Diagnosis of amniotic embolism by using the fluorescent characteristic of coproporphyrin, a component of fetal urine.
- 472. The Relationship between Platelet Derived Growth Factor (PDGF) and Proliferation of Uterine Smooth Muscle Cells : Immunohistochemical Study
- 308. Clinical Significance of Urinary Trypsin Inhibitor (UTI) in Amniotic Fluid
- 253. The Usefulness of Placental Plasminogen Activator (PPA) as a Marker Protein of Malignant Tumors
- 146. Significance of Urinary Meconium Index (UMI) in Diagnosis of Amniotic Fluid Embolism
- O-39 A prospective study on congenital cytomegalovirus infection
- 31O. Biochemical Approach to Cause of Premature Rupture of Membranes : Collagen Degradation in Amnion Due to Neutrophil and Meconium
- 144. Delivery in the Case of Congenital Afibrinogenemia the First Case in the World : Fibrinogen and Fertility
- S-15 17β-estradiol upregulates thrombomodulin expression in combination with Menaquinone4(MK4)
- 178 A New Amnioscope by Using Image fiber with Fluorescent Technique.
- 142 Plasma Zinc Coproporphyrin Determination at Delivery : New diagnosis method for amniotic fluid embolism.
- 114 Role of Fibronectin receptor in the maintenance of pregnancy.
- 417 The early detection of chorioamnionitis by measurement of elastase activity of cervical mucus.
- 426 Studies on the Cardiotocograms Recorded by a flexible ultrasound transducer.
- 186 Pharmacodynamic study of UTI used in fetal distress therapy.
- 138. Studies on Placental Plasminogen Activator (PPA)
- 34. The Antithrombin III (AT-III) Therapy to EPH Gestosis
- 279.The Serum Placental Plasminogen Activator (PPA) Level in the Patients of Malignant Tumors : XXXXVII Malignant Tumor(VII)
- 143. The System for Clinical Use of Measuring Meconium Staining in Amniotic Fluids through Fluorescent Technique
- 60 Concentrated vitamin K in breast milk and the effect on infants after vitamin K prescription to mothers.
- 378. The Role of Human Neutrophil Elastase in the Premature Rupture of Membranes
- 356. Study on Pancreatic Secretory Trypsin Inhibitor in Amniotic Fluid
- 173. Variations in Coagulation Factors during Fetal Period
- 244. Pathophysiologic Mechanism of Sinusoidal Heart Rate(SHR) and Overshoot Acceleration(OA)
- 242. Placental Leucine Aminopeptidase which is Measured by a New Method, in Normal and Complicated Pregnancies
- SCREENING FOR PANCREAS SPECIFIC GENES USING XENOPUS ANIMAL CAPS(Developmental Biology)(Proceeding of the Seventy-Third Annual Meeting of the Zoological Society of Japan)
- 264. Discussion of 8 Cases (10 Pregnancies) of Aplastic Anemia Complicated with Pregnancy
- 256. Discussion of 8 Cases (10 Pregnancies) of Aplastic Anemia Complicated with Pregnancy
- 245. Blood Coagulation Factor Deficiency and Pregnancy
- 206. Clinical and Experimental Studies on the Haemostatic Mechanism of Obstetrical Haemorrhage
- 551 A case report of a fetus with urethral obstruction at early gestation : The antenatal assessment of the fetal renal function was compared with the renal histological findings at autopsy.
- 15 The relation between granulocyte elastase and urinary type plasminogen activator in uterine cervical cancer.
- 33 Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plaminogen activator (pro-uPA).